LISA SULLIVAN to Humans
This is a "connection" page, showing publications LISA SULLIVAN has written about Humans.
Connection Strength
0.260
-
Common Statistical Pitfalls in Basic Science Research. J Am Heart Assoc. 2016 09 29; 5(10).
Score: 0.015
-
Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004 May 30; 23(10):1631-60.
Score: 0.006
-
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth. JAMA Netw Open. 2021 08 02; 4(8):e2121726.
Score: 0.005
-
Correlates of violent assault among young male primary care patients. J Health Care Poor Underserved. 2001 Feb; 12(1):103-12.
Score: 0.005
-
The doctor-patient relationship and HIV-infected patients' satisfaction with primary care physicians. J Gen Intern Med. 2000 Jul; 15(7):462-9.
Score: 0.005
-
Association of Parental Obesity and Diabetes Mellitus With Circulating Adipokines in Nonobese Nondiabetic Offspring. J Am Heart Assoc. 2017 Jul 16; 6(7).
Score: 0.004
-
Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study. J Am Heart Assoc. 2017 Jul 16; 6(7).
Score: 0.004
-
Revised Framingham Stroke Risk Profile to Reflect Temporal Trends. Circulation. 2017 Mar 21; 135(12):1145-1159.
Score: 0.004
-
Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study. J Am Heart Assoc. 2016 07 06; 5(7).
Score: 0.004
-
Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study. Atherosclerosis. 2016 May; 248:245-51.
Score: 0.003
-
Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort. Hypertension. 2016 Feb; 67(2):294-300.
Score: 0.003
-
Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment. J Am Heart Assoc. 2015 Nov 20; 4(11).
Score: 0.003
-
Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016 Jan; 13(1):233-40.
Score: 0.003
-
Association of soda consumption with subclinical cardiac remodeling in the Framingham heart study. Metabolism. 2015 Feb; 64(2):208-12.
Score: 0.003
-
Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ Cardiovasc Genet. 2014 Dec; 7(6):864-72.
Score: 0.003
-
Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering. Metab Syndr Relat Disord. 2014 Sep; 12(7):372-80.
Score: 0.003
-
Assessing the incremental predictive performance of novel biomarkers over standard predictors. Stat Med. 2014 Jul 10; 33(15):2577-84.
Score: 0.003
-
Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2014 Apr; 7(2):307-12.
Score: 0.003
-
Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes. Eur Heart J. 2014 Nov 07; 35(42):2980-7.
Score: 0.003
-
Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. J Am Heart Assoc. 2013 Sep 03; 2(5):e000126.
Score: 0.003
-
Multilevel modeling versus cross-sectional analysis for assessing the longitudinal tracking of cardiovascular risk factors over time. Stat Med. 2013 Dec 10; 32(28):5028-38.
Score: 0.003
-
Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail. 2013 Aug; 15(8):843-9.
Score: 0.003
-
Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol (Oxf). 2013 Apr; 78(4):629-34.
Score: 0.003
-
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013 Jan 01; 127(1):33-8.
Score: 0.003
-
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. Am J Cardiol. 2013 Jan 15; 111(2):219-24.
Score: 0.003
-
Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension. 2012 Dec; 60(6):1393-9.
Score: 0.003
-
High-risk profiles for nursing home admission. Gerontologist. 1992 Oct; 32(5):634-40.
Score: 0.003
-
Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J Clin Endocrinol Metab. 2012 Oct; 97(10):E1943-7.
Score: 0.003
-
Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study. Int J Androl. 2012 Dec; 35(6):775-782.
Score: 0.003
-
Age of natural menopause and atrial fibrillation: the Framingham Heart Study. Am Heart J. 2012 Apr; 163(4):729-34.
Score: 0.003
-
Circulating vascular growth factors and central hemodynamic load in the community. Hypertension. 2012 Apr; 59(4):773-9.
Score: 0.003
-
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2012 Feb 15; 109(4):533-7.
Score: 0.003
-
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J. 2012 Jan; 163(1):119-124.e1.
Score: 0.003
-
Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort. J Nutr. 2011 Dec; 141(12):2186-90.
Score: 0.003
-
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort. Clin Chem Lab Med. 2011 Nov; 49(11):1907-10.
Score: 0.003
-
Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. Circ Res. 2011 Aug 19; 109(5):554-63.
Score: 0.003
-
Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia. 2011 May; 54(5):1019-24.
Score: 0.002
-
Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension. 2011 Mar; 57(3):390-6.
Score: 0.002
-
P wave duration and risk of longitudinal atrial fibrillation in persons = 60 years old (from the Framingham Heart Study). Am J Cardiol. 2011 Mar 15; 107(6):917-921.e1.
Score: 0.002
-
Type 2 diabetes risk in persons with dysglycemia: the Framingham Offspring Study. Diabetes Res Clin Pract. 2011 Apr; 92(1):124-7.
Score: 0.002
-
Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am J Clin Nutr. 2011 Feb; 93(2):261-6.
Score: 0.002
-
Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010 Nov 22; 170(21):1909-17.
Score: 0.002
-
Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. Am Heart J. 2010 Oct; 160(4):715-20.
Score: 0.002
-
P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol. 2010 Oct; 15(4):344-52.
Score: 0.002
-
Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study. Circulation. 2010 Aug 31; 122(9):884-90.
Score: 0.002
-
Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation. 2010 Aug 10; 122(6):570-8.
Score: 0.002
-
Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol. 2010 Jul; 30(7):1479-84.
Score: 0.002
-
Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community. Circ Cardiovasc Genet. 2010 Jun; 3(3):300-6.
Score: 0.002
-
Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community. Circulation. 2010 Feb 09; 121(5):667-74.
Score: 0.002
-
Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010 Jan 19; 121(2):200-7.
Score: 0.002
-
P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):77-84.
Score: 0.002
-
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism. 2010 Apr; 59(4):540-6.
Score: 0.002
-
Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort. Clin Chem. 2009 Aug; 55(8):1539-45.
Score: 0.002
-
Relation of serum leptin with cardiac mass and left atrial dimension in individuals >70 years of age. Am J Cardiol. 2009 Aug 15; 104(4):602-5.
Score: 0.002
-
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation. 2009 Jun 23; 119(24):3085-92.
Score: 0.002
-
Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke. 2009 Aug; 40(8):2715-9.
Score: 0.002
-
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation. 2009 Mar 31; 119(12):1592-600.
Score: 0.002
-
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009 Feb 28; 373(9665):739-45.
Score: 0.002
-
Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur Heart J. 2009 May; 30(9):1121-7.
Score: 0.002
-
Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care. 2009 Apr; 32(4):612-6.
Score: 0.002
-
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008 Nov 20; 359(21):2208-19.
Score: 0.002
-
Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample. Atherosclerosis. 2009 May; 204(1):282-7.
Score: 0.002
-
Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab. 2008 Aug; 93(8):3165-72.
Score: 0.002
-
Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). Am J Cardiol. 2008 Feb 15; 101(4):497-501.
Score: 0.002
-
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007 Aug 15; 298(7):776-85.
Score: 0.002
-
The contribution of birth defects to preterm birth and low birth weight. Obstet Gynecol. 2007 Aug; 110(2 Pt 1):318-24.
Score: 0.002
-
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007 Jul 31; 116(5):480-8.
Score: 0.002
-
Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study. Psychosom Med. 2007 Jul-Aug; 69(6):509-13.
Score: 0.002
-
Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation. 2007 Jul 24; 116(4):375-84.
Score: 0.002
-
The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med. 2007 Jul; 20(7):509-13.
Score: 0.002
-
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007 May 28; 167(10):1068-74.
Score: 0.002
-
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007 May 14; 167(9):879-85.
Score: 0.002
-
Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007 Jun; 56(6):1718-26.
Score: 0.002
-
Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007 May; 30(5):1219-25.
Score: 0.002
-
Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring. Hypertension. 2007 Mar; 49(3):439-45.
Score: 0.002
-
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006 Aug; 91(8):2906-12.
Score: 0.002
-
How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts. J Subst Abuse Treat. 2006 Mar; 30(2):121-8.
Score: 0.002
-
Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes. 2006 Feb; 55(2):530-7.
Score: 0.002
-
Social networks and inflammatory markers in the Framingham Heart Study. J Biosoc Sci. 2006 Nov; 38(6):835-42.
Score: 0.002
-
Association of educational level with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2006 Apr 01; 163(7):622-8.
Score: 0.002
-
Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med. 2006 Jan 09; 166(1):106-11.
Score: 0.002
-
Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation. 2006 Jan 03; 113(1):20-9.
Score: 0.002
-
Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005 Nov; 54(11):3252-7.
Score: 0.002
-
Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging. 2005 Dec; 26 Suppl 1:11-6.
Score: 0.002
-
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005 Dec 01; 80(1):45-53.
Score: 0.002
-
Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Med. 2005 Sep-Oct; 67(5):692-6.
Score: 0.002
-
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005 Dec 01; 80(1):19-32.
Score: 0.002
-
Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol. 2005 Oct 01; 162(7):644-53.
Score: 0.002
-
Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005 Mar 15; 142(6):393-402.
Score: 0.002
-
Coronary heart disease risk in men and the epidemic of overweight and obesity. Int J Obes (Lond). 2005 Mar; 29(3):317-23.
Score: 0.002
-
Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med. 2005 Jan-Feb; 67(1):24-30.
Score: 0.002
-
Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005 Jan; 45(1):28-33.
Score: 0.002
-
C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004 Jul 27; 110(4):380-5.
Score: 0.002
-
Does job strain increase the risk for coronary heart disease or death in men and women? The Framingham Offspring Study. Am J Epidemiol. 2004 May 15; 159(10):950-8.
Score: 0.002
-
The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004 Mar; 27(3):704-8.
Score: 0.002
-
Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation. 2004 Mar 16; 109(10):1267-71.
Score: 0.002
-
Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J. 2004 Mar; 25(6):523-30.
Score: 0.002
-
Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004 Feb; 35(2):404-9.
Score: 0.002
-
Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study. Hypertension. 2003 Dec; 42(6):1100-5.
Score: 0.001
-
Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med. 2003 Oct 21; 139(8):642-8.
Score: 0.001
-
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003 Mar 25; 107(11):1486-91.
Score: 0.001
-
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003 Feb; 27(2):260-8.
Score: 0.001
-
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002 Sep 09; 162(16):1867-72.
Score: 0.001
-
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000 Jun 15-30; 19(11-12):1495-522.
Score: 0.001
-
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med. 1997 Jan; 102(1):38-47.
Score: 0.001